logo
Plus   Neg
Share

VEEV Gains 25% After Featuring On STI

The stock, Veeva Systems Inc. (VEEV), featured on our 'Short-Term Investor' On November 27, 2019, at an opening price of $165.17. On May 26, 2020, the stock touched a 52-week high of $206.90, representing a gain of 25.3%. VEEV closed Thursday's trade at $204.20, up $12.21 or 6.36%.

Why we published this stock?

Veeva Systems reported better-than-expected third-quarter results, continuing its earnings surprise streak into another quarter. Annual guidance numbers also looked better than analyst estimates.

Upbeat Q3 Results

Third quarter net income was $82.2 million or $0.52 per share, compared to $64.1 million or $0.41 per share a year ago.

Non-GAAP net income was $95.4 million or $0.60 per share, compared to $70.6 million or $0.45 per share last year.

Analysts polled by Thomson Reuters expected earnings of $0.54 per share for the quarter. Analysts' estimate typically exclude certain special items.

Total revenues for the third quarter were $280.9 million, up from $224.7 million one year ago, an increase of 25% year-over-year.

“Our outperformance in both Veeva Commercial Cloud and Veeva Vault reflects the tremendous opportunity we have in life sciences,” said CFO Tim Cabral. “We’re continuing our investments to drive customer success and long-term growth in our aim to become the most strategic partner to the industry.”

Q4, FY20 Outlook

For the fourth quarter, the company then projected non-GAAP earnings in the range of $0.51 - $0.52 per share, and total revenues between $296 million - $299 million. Wall Street analysts estimated earnings of $0.52 per share and revenue of $279.86 million for the quarter.

For fiscal year ending January 31, 2020, the company then expected non-GAAP earnings to be in the range of $2.16 - $2.17 per share, and total revenues between $1.088 billion and $1.091 billion. Eighteen Wall Street analysts then had a consensus earnings estimate of $2.12 per share on revenue of $1.07 billion for fiscal 2020.

Free Sign Up
Free Sign Up

Short-Term Investor Top Perfomers
Pub. DateCompany% Gain
01/10/2018 TNDM + 696.14
05/08/2018 TREX + 211.39
05/17/2016 MIME + 207.12
01/07/2016 QUAD + 198.90
05/24/2016 EXEL + 185.08
08/08/2019 ACMR + 184.92
01/30/2015 CORT + 161.51
01/19/2017 TAL + 149.84
08/20/2015 MSG + 141.43
01/09/2017 EXAS + 140.34
Complete Performance
Under the Radar Top Perfomers
Pub. DateCompany% Gain
04/27/2020 MDGS + 108.50
02/20/2013 IKNX + 99.41
08/13/2014 INGN + 98.42
11/11/2014 CYAN + 89.14
02/22/2019 BOOM + 87.02
12/11/2014 INTL + 86.33
03/07/2019 FLY + 81.83
10/23/2014 OFLX + 81.26
08/14/2014 AMOT + 79.00
02/07/2018 MHH + 78.84
09/11/2014 MSON + 78.44
Complete Performance
Emerging Biostocks Top Perfomers
Pub. DateCompany% Gain
04/19/2017 MRTX + 1576
07/17/2018 AMRN + 737
04/05/2017 MYOK + 734
10/03/2019 CNST + 552
02/11/2016 TBRA + 542
11/25/2017 CBIO + 464
09/03/2019 APLT + 437
11/03/2019 THOR + 362
09/21/2018 CCXI + 339
11/23/2017 ARGX + 302
02/05/2018 VKTX + 295
01/18/2018 ADVM + 218
06/06/2018 CSBR + 216
03/26/2020 MRNA + 216
04/06/2020 TBIO + 184
03/03/2020 OVID + 181
04/08/2019 SOLY + 170
09/10/2018 NTEC + 140
06/20/2019 ZYXI + 106
Complete Performance
Free Sign Up